||June 19, 2020
Rheumatology News Roundup: Is it axSpA or fibromyalgia?
Author(s)Rheumatology Network Editorial Staff
In this week's news roundup from Rheumatology Network, we feature a series of studies that focus on new treatments for rheumatic disease. We also highlight the newly approved secukinumab (Cosentyx, Novartis) for active non-radiographic axial spondyloarthritis (axSpA). Today, we feature a discussion with Dr. Alexis Ogdie-Beatty and Kelly Gavigan, the lead researcher on a recent study about the overlap between axSpA and fibromyalgia.
Advertisement
The study was presented at the EULAR e-Congress held online earlier this month.
In this interview, Dr. Ogdie, of Penn Medicine, and Ms. Gavigan, of the Global Healthy Living Foundation, discuss the overlap between fibromyalgia symptoms and axSpA.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Moving the Needle in Medicine: Mentorship, Medicine, and the Making of an Innovator, With Jim Januzzi, MD
2
6 Gastroenterology Headlines You Missed in May 2026
3
Inhaled Treprostinil Improves IPF Outcomes in Phase 3 TETON-1 Trial
4
Q&A: How Lifelong Burdens Are Shaped by Childhood Eczema, With Delphine Kerob, MD
5





















































